What medication can lower elevated serum uric acid levels?

Medications to Reduce Elevated Serum Uric Acid

Allopurinol is the preferred first-line medication to lower elevated serum uric acid, started at 100 mg daily (or 50 mg daily if chronic kidney disease stage ≥4) and titrated upward by 100 mg every 2-5 weeks until serum urate reaches <6 mg/dL. 1, 2

When to Initiate Urate-Lowering Medication

Strong Indications (Treat Regardless of Uric Acid Level)

• Presence of subcutaneous tophi detected on physical examination or imaging 1, 2
• Frequent gout flares (≥2 per year) 1, 2
• Radiographic joint damage attributable to gout 1, 2

Conditional Indications (Consider After First Gout Flare)

• Chronic kidney disease stage ≥3 (eGFR <60 mL/min) 1, 2
• Serum urate >9 mg/dL after first flare 2
• History of kidney stones (urolithiasis) 1, 2

Do NOT Treat Asymptomatic Hyperuricemia

• Pharmacologic treatment of asymptomatic hyperuricemia is explicitly not recommended to prevent gout, cardiovascular disease, or renal disease 2
• Even at levels >9 mg/dL without symptoms, only 20% develop gout within 5 years 2
• The number needed to treat is 24 patients for 3 years to prevent a single gout flare 2

Allopurinol Dosing Protocol

Starting Dose

• 100 mg daily for normal renal function 1, 2
• 50 mg daily for CKD stage 4 or worse 1, 2

Titration Strategy

• Increase by 100 mg every 2-5 weeks based on serum urate monitoring 1, 2
• Most patients require >300 mg daily to achieve target 1, 2
• Maximum dose is 800 mg daily 2
• Doses above 300 mg can be safely used even in renal impairment with appropriate monitoring 1

Target Serum Urate Levels

• <6 mg/dL for all gout patients 1, 2
• <5 mg/dL for severe gout (tophi, chronic arthropathy, frequent attacks) until crystal dissolution 1, 2

Mandatory Flare Prophylaxis

When starting or escalating allopurinol, you must provide anti-inflammatory prophylaxis to prevent acute gout flares triggered by rapid urate reduction. 1, 2

• Colchicine 0.5-1 mg daily for at least 6 months 1, 2
• Reduce colchicine dose in renal impairment 1, 2
• Avoid colchicine with strong P-glycoprotein/CYP3A4 inhibitors 1, 2
• If colchicine contraindicated: use low-dose NSAIDs or low-dose glucocorticoids 1, 2

Monitoring Schedule

• During titration: check serum urate every 2-5 weeks 1, 2
• After reaching target: monitor every 6 months indefinitely 1, 2
• Continue therapy lifelong once started 2

Alternative Medications When Allopurinol Cannot Be Used

Febuxostat (Alternative Xanthine Oxidase Inhibitor)

• Preferred first-line alternative when allopurinol is contraindicated or not tolerated 3
• Start at 40 mg daily, no dose adjustment needed in mild-moderate renal impairment 4, 3
• FDA black box warning: conditionally recommend switching from febuxostat in patients with established cardiovascular disease 4, 3

Probenecid (Uricosuric Agent)

• Alternative when xanthine oxidase inhibitors fail 1
• Requires creatinine clearance >50 mL/min 1, 2, 3
• Contraindicated with kidney stones 1, 3
• Dose: 1-2 g/day 1

Benzbromarone (Uricosuric Agent)

• Can be used in mild-moderate renal insufficiency 1, 3
• Small risk of hepatotoxicity requiring monitoring 1, 4
• More effective than allopurinol in renal impairment 1

Combination Therapy for Refractory Cases

• Combine xanthine oxidase inhibitor with uricosuric agent when monotherapy fails to achieve target 3
• Example: febuxostat plus probenecid or benzbromarone 3

Adjunctive Lifestyle Modifications

While lifestyle changes alone achieve only 10-18% reduction in serum urate, they should accompany pharmacologic therapy: 3

• Weight reduction in overweight/obese patients 1, 2
• Limit alcohol, especially beer and spirits 1, 2
• Avoid sugar-sweetened beverages and high-fructose corn syrup 1, 2
• Reduce purine-rich foods (organ meats, shellfish) 1, 2
• Encourage low-fat dairy products and vegetables 1, 2
• Discontinue non-essential urate-elevating medications (thiazide/loop diuretics when alternatives available) 2

Medications That Incidentally Lower Uric Acid

Losartan (Angiotensin Receptor Blocker)

• Only ARB with clear evidence of lowering serum uric acid 5, 6
• Consider as first-line antihypertensive in patients with hypertension and elevated uric acid 5
• Combination losartan/hydrochlorothiazide decreased uric acid by 0.44 mg/dL versus other ARBs 6

Atorvastatin

• Most effective statin for lowering uric acid (mean reduction 37.93 μmol/L) 7
• Pravastatin and simvastatin also reduce uric acid, but less effectively 7
• Consider atorvastatin as preferred statin in patients with or at risk of hyperuricemia 7

Common Pitfalls to Avoid

• Undertreatment with fixed 300 mg allopurinol dose: most patients need higher doses to reach target 1, 2
• Starting urate-lowering therapy without flare prophylaxis: significantly increases acute gout attacks and treatment failure 2
• Stopping prophylaxis before 6 months: increases breakthrough flare risk 2
• Treating asymptomatic hyperuricemia: exposes patients to unnecessary medication risks without proven benefit 2
• Discontinuing therapy during acute flare: continue urate-lowering medication and add anti-inflammatory treatment 2
• Using probenecid in renal impairment: contraindicated when creatinine clearance <50 mL/min 1, 2, 3